1. Home
  2. LUNG vs GSRT Comparison

LUNG vs GSRT Comparison

Compare LUNG & GSRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LUNG
  • GSRT
  • Stock Information
  • Founded
  • LUNG 1995
  • GSRT 2023
  • Country
  • LUNG United States
  • GSRT United States
  • Employees
  • LUNG N/A
  • GSRT N/A
  • Industry
  • LUNG Industrial Specialties
  • GSRT
  • Sector
  • LUNG Health Care
  • GSRT
  • Exchange
  • LUNG Nasdaq
  • GSRT Nasdaq
  • Market Cap
  • LUNG 65.6M
  • GSRT 303.7M
  • IPO Year
  • LUNG 2020
  • GSRT 2024
  • Fundamental
  • Price
  • LUNG $1.56
  • GSRT $10.36
  • Analyst Decision
  • LUNG Buy
  • GSRT Strong Buy
  • Analyst Count
  • LUNG 7
  • GSRT 1
  • Target Price
  • LUNG $7.66
  • GSRT $19.00
  • AVG Volume (30 Days)
  • LUNG 480.4K
  • GSRT 453.0K
  • Earning Date
  • LUNG 10-29-2025
  • GSRT 01-01-0001
  • Dividend Yield
  • LUNG N/A
  • GSRT N/A
  • EPS Growth
  • LUNG N/A
  • GSRT N/A
  • EPS
  • LUNG N/A
  • GSRT 0.19
  • Revenue
  • LUNG $90,549,000.00
  • GSRT N/A
  • Revenue This Year
  • LUNG $10.30
  • GSRT N/A
  • Revenue Next Year
  • LUNG $14.72
  • GSRT N/A
  • P/E Ratio
  • LUNG N/A
  • GSRT $53.50
  • Revenue Growth
  • LUNG 18.24
  • GSRT N/A
  • 52 Week Low
  • LUNG $1.47
  • GSRT $9.86
  • 52 Week High
  • LUNG $9.37
  • GSRT $11.49
  • Technical
  • Relative Strength Index (RSI)
  • LUNG 38.12
  • GSRT 42.29
  • Support Level
  • LUNG $1.54
  • GSRT $10.35
  • Resistance Level
  • LUNG $1.63
  • GSRT $10.45
  • Average True Range (ATR)
  • LUNG 0.12
  • GSRT 0.05
  • MACD
  • LUNG 0.02
  • GSRT 0.01
  • Stochastic Oscillator
  • LUNG 6.45
  • GSRT 10.10

About LUNG Pulmonx Corporation

Pulmonx Corp is a commercial-stage medical technology company. It provides a minimally invasive treatment for patients with severe emphysema, a form of chronic obstructive pulmonary disease (COPD). The company's solutions are comprised of the Zephyr Endobronchial Valve, the Chartis Pulmonary Assessment System and the StratX Lung Analysis Platform. It generates revenue through the sale of products to distributors and hospitals in the United States which a key revenue generating market, Europe, Middle-East and Africa, Asia Pacific and other regions.

About GSRT GSR III Acquisition Corp. Ordinary Shares

GSR III Acquisition Corp is a blank check company.

Share on Social Networks: